Head of Business Development, Life Sciences

Osmind is the platform for clinicians and researchers advancing new life-saving mental health treatments. Today, mental health disorders are one of the leading causes of death worldwide, especially among young adults, and are tied to shortening lifespans. While there have been developments in new psychiatric medications since the first FDA approval in 1954, today there is a growing movement among clinicians, patients, and researchers who are recognizing the need to accelerate new science.

The Osmind treatment platform is currently used by leading interventional mental health practices to safely administer, monitor, and analyze the use of TMS, ECT, ketamine, SPRAVATO®, and psychedelic medicine for people living with moderate to severe mental health conditions. The core EHR technology is precisely developed for interventional treatment workflows and designed to support a strong therapeutic alliance, including journaling tools and assistance with health plan reimbursement, which is a significant access hurdle for millions of patients.

Research from our platform is already helping to set new standards for mental health interventions. In the largest published real-world analysis of ketamine infusion therapy (KIT), we teamed up with Stanford University School of Medicine to share findings in the Journal of Affective Disorders (March 2022).

Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists. We are backed by top investors DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator.

The Opportunity

We are a series B funded Public Benefit Corporation (PBC) building something that actually moves the needle on the global mental health crisis. (See here for an article our cofounder Jimmy wrote about PBC’s.)

We are looking for a Head of Business Development, Life Sciences. This person will play a foundational role in Osmind's growth by leading our commercial efforts with life science companies, such as biopharma and diagnostics companies. You will work closely with the executive and medical affairs teams to build out our entire function from scratch. This is a tremendous opportunity to lay the foundation for a major function in a fast-paced environment with a team that cares deeply about making an impact on the patients who need it the most.

Responsibilities

• Lead our go-to-market effort of our product offerings for pharma spanning RWE, biomarker discovery, clinical trial recruitment and site selection, and more. Develop our value proposition and repeatable sales process for the discovery, development, and delivery of new therapeutics for neuropsychiatry
• Spearhead key strategic go-to-market decision making which will impact broader company strategy. Key questions include:
• 1. Which pharma companies and programs (modalities, mechanisms of action, stages of development) should we target? How should we sequence and prioritize our GTM strategy?
• 2. What are the best structures to maximize value and recurring, predictable revenue? What is our pricing strategy?
• 3. How can we best adopt a land and expand strategy?
• Work with our VP Life Sciences to needs find and deeply understand what pharma needs and translate those findings back to our clinical, data science, product, and engineering organizations
• Develop our sales pipeline. Leverage connections, get intros, lead calls, sell to biopharma. Maintain robust relationships with pharma
• Achieve revenue targets by selling our capabilities and closing complex, multi-year strategic collaborations
• Serve as point person liaising with pharma team. Negotiate business terms and creative deal structures. Handle all of the detailed deal scoping, approvals, procurement, finance, legal, contracting, and more
• Maintain a deep understanding of R&D pipelines, M&A activity, funding activity, asset development, etc. of potential customers and competitors
• Build out and manage the commercial team as we scale our GTM strategy

Requirements

• 5+ years within pharma BD or selling into pharma (e.g. RWE companies, CRO), with multiple deals sourced, negotiated, and closed; 10+ years of experience total
• Strong interest in and understanding of RWE value propositions from clinical development through commercial
• Exceptional strategic leadership skills, executive presence, and communication. You see the forest through the trees and can help navigate complex business and commercial decisions internally and externally with a high level of credibility
• Comprehensive understanding of the Life Sciences buying process. You know how to navigate pharma inside and out, including which groups to approach, how to move deals along, and key stakeholders to build relationships with
• Comfort with and excitement around uncertainty as we launch our pharma-facing go-to-market strategy and build a repeatable sales motion

Preferred

• PhD in a scientific discipline, or MD to be able to better understand pharma technical requirements
• MBA, for business acumen, or JD, for structuring skills, also would be a plus
• Rolodex in neuropsychiatry pharma to take off on day one
• Experience selling or purchasing RWE solutions
• Strong interest in new-age mental health treatments such as psychedelic medicine

Osmind is a public benefit corporation and platform for clinicians and researchers advancing new life-saving mental health treatments. We recently published our first Public Benefit Report that chronicles how our team of scientists, technologists, and psychiatrists have been working to help solve the worldwide mental health crisis, advance responsible innovation and research, and help ensure robust access to care for patients of all backgrounds. Read the report here: https://www.osmind.org/pbc.